BioXcel Therapeutics Inc To Host BXCL701 Key Opinion Leader Day Transcript

Feb 21, 2023 / 06:00PM GMT
Vincent J. O'Neill - BioXcel Therapeutics, Inc. - Senior VP and Chief Research & Development Officer of OnkosXcel Therapeutics

Okay. I think we're ready to get started. So good afternoon. Welcome, everyone, and thank you for attending our BioXcel Key Opinion Leader Day event, either in person or virtually because I know we have about 40 people dialed in at this point. So my name is Dr. Vince O'Neill. I am Head of R&D at OnkosXcel, and I will be moderating the proceedings today.

So just a reminder that we may make during discussions or indeed in the slide presentations, forward-looking statements, and these are subject to risks and uncertainty, subject to change depending on market conditions, et cetera.

So I'm very excited to say that today over the next 2 hours, we're really going to do a deep dive into BXCL701, actually for the first time. So I'm really excited about that. And talking about the signs behind the molecule and also talk about its potential in the clinic. So to help us do that, we've invited 3 distinguished academic guests to be with us today. Dr.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot